This course is developed by Medscape Education Global. Medscape is one of the leading digital platforms for medical education. A comprehensive array of innovative formats, in multiple languages, insures the right educational solution is available to best achieve desired objectives—from text-based articles to state-of-the-art multimedia formats and the most sophisticated simulation environments. Activity formats include Clinical Insights, Expert Perspective, Instructional Series Programming, Next-Generation Symposia, Patient-Case Approaches, including Simulation and Clinical Advances.
Data from recent clinical and cardiovascular outcomes trials (CVOTs) suggest that glucagonlike peptide-1 (GLP-1) receptor agonists have multi-factorial benefits beyond glycaemic control.
On this programme, you'll find a collection of dynamic, interactive educational courses addressing the latest evidence for managing individuals with diabetes and other disordes - especially established or risk factors for atheroscletoric cardiovascular disease (ASCVD) and chronic kidney disease (CKD)
Made for: Specialists, Primary Care Physicians
Disease areas: Diabetes, Cardiovascular Disease, Chronic Kidney Disease
Developed by: Medscape Education Global